Physician

Hamid Joseph Obeid, MD

According to 2025 Medicare claims, Hamid Obeid, MD (NPI: 1548251663) practices otolaryngology in the Utica-Rome, NY market, with the plurality of this provider's patient population coming from Oneida, NY. This provider's primary affiliated billing organization is HJ OBEID MD PLLC (NPI: 1205229903; TIN: 473324277) and primary practice location at 13440-2866.

Obeid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 346 traditional Medicare patients, billed 2,444 HCPCS/CPT codes, and received $425,840 in Medicare payments. The top billing code was 31237 (Biopsy or removal of nasal polyp or tissue using an endoscope). Part D data shows 1,351 prescription claims across 346 beneficiaries totaling $138,357 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 56 records totaling $2,813. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $629,367 to $425,840. In contrast, Part D prescription costs have risen steadily, from $67,048 to $138,357. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$315K$629K2015 Medicare payment: $629,367 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $541,027 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $464,850 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $422,197 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $338,981 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $287,782 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $445,607 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $426,046 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $314,540 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $425,840 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157164,770$629,367
20167284,850$541,027
20176784,370$464,850
20186083,812$422,197
20195573,277$338,981
20204242,694$287,782
20214183,297$445,607
20224142,708$426,046
20234072,442$314,540
20243462,444$425,840

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$69K$138K2015 Drug cost: $67,048 (USD; Tot_Drug_Cst)2016 Drug cost: $52,257 (USD; Tot_Drug_Cst)2017 Drug cost: $62,731 (USD; Tot_Drug_Cst)2018 Drug cost: $78,510 (USD; Tot_Drug_Cst)2019 Drug cost: $71,982 (USD; Tot_Drug_Cst)2020 Drug cost: $76,553 (USD; Tot_Drug_Cst)2021 Drug cost: $79,584 (USD; Tot_Drug_Cst)2022 Drug cost: $35,410 (USD; Tot_Drug_Cst)2023 Drug cost: $94,742 (USD; Tot_Drug_Cst)2024 Drug cost: $138,357 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153891,549$67,048
20163551,291$52,257
20174241,643$62,731
20184941,898$78,510
20194451,807$71,982
20204181,680$76,553
20213491,406$79,584
2022315965$35,410
20233951,564$94,742
20243461,351$138,357

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
31237Biopsy or removal of nasal polyp or tissue using an endoscope99240$265
31231Diagnostic exam of nasal passages using an endoscope159287$122
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more313711$57
92504Exam of ear using a microscope7987$21
69209Removal of impacted ear wax by washing117160$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab13364$44,641
Dexamethasone Sodium PhosphateDexamethasone Sodium Phosphate3125,229$14,933
XhanceFluticasone Propionate18600$12,724
Fluticasone PropionateFluticasone Propionate30012,525$4,269
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth25324$3,275

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.56$2,813AERIN MEDICAL INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Hamid Joseph Obeid, MD?

Tedicare shows public-source Medicare data for Hamid Joseph Obeid, MD (NPI 1548251663), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hamid Joseph Obeid, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hamid Joseph Obeid, MD?

Hamid Joseph Obeid, MD is linked to HJ OBEID MD PLLC (billing NPI 1205229903) in the available physician profile data.

Does Hamid Joseph Obeid, MD have Open Payments data?

Hamid Joseph Obeid, MD has 56 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.